IRIS
IEZZI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.781
EU - Europa 4.006
AS - Asia 2.985
SA - Sud America 353
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 7
Totale 12.185
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.723
SG - Singapore 1.078
CN - Cina 983
IT - Italia 784
IE - Irlanda 708
UA - Ucraina 604
SE - Svezia 483
TR - Turchia 473
GB - Regno Unito 390
BR - Brasile 323
DE - Germania 323
FR - Francia 278
IN - India 270
FI - Finlandia 151
RU - Federazione Russa 110
VN - Vietnam 57
NL - Olanda 44
CZ - Repubblica Ceca 39
HK - Hong Kong 35
BE - Belgio 28
CA - Canada 26
AT - Austria 22
IQ - Iraq 17
ZA - Sudafrica 15
IR - Iran 13
MX - Messico 13
EU - Europa 12
BD - Bangladesh 11
PL - Polonia 11
MA - Marocco 9
VE - Venezuela 8
AR - Argentina 7
GR - Grecia 7
IL - Israele 7
AU - Australia 5
ES - Italia 5
PK - Pakistan 5
SA - Arabia Saudita 5
BZ - Belize 4
CL - Cile 4
JP - Giappone 4
KE - Kenya 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CO - Colombia 3
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
OM - Oman 3
PY - Paraguay 3
UZ - Uzbekistan 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
EC - Ecuador 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
ID - Indonesia 1
LB - Libano 1
LK - Sri Lanka 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
UY - Uruguay 1
Totale 12.185
Salva come PNG Salva come JPEG
Città #
Chandler 896
Singapore 769
Jacksonville 704
Dublin 698
Princeton 300
Southend 286
Beijing 265
Dearborn 233
Izmir 225
Nanjing 187
Ashburn 169
Ann Arbor 155
Altamura 134
Santa Clara 134
Wilmington 134
Chieti 121
New York 112
The Dalles 112
Cambridge 111
Boardman 98
Pescara 98
Tongling 78
Nanchang 63
Munich 62
Los Angeles 54
Woodbridge 50
Helsinki 35
Hebei 34
Hong Kong 34
Grevenbroich 33
Dong Ket 31
Tianjin 30
Washington 30
Shenyang 29
Brno 28
Rome 28
Nuremberg 27
São Paulo 27
Hefei 26
Kunming 24
Seattle 24
Brussels 23
Norwalk 23
Brooklyn 21
Changsha 21
Ancona 20
Frankfurt am Main 19
London 19
Jiaxing 18
Turku 18
Milan 17
Castignano 16
Chicago 16
Hangzhou 16
Jinan 16
San Mateo 16
Augusta 15
Amsterdam 14
Orange 14
Vienna 14
Falls Church 13
Houston 13
Rio de Janeiro 13
Camerino 12
Pune 12
Guangzhou 11
Ho Chi Minh City 11
Johannesburg 11
Leawood 11
San Francisco 11
Ascoli Piceno 10
Toronto 10
Ardabil 9
Bologna 9
Changchun 9
Lanzhou 9
Napoli 9
Verona 9
Bari 8
Boston 8
Hanoi 8
Baghdad 7
Belo Horizonte 7
Chennai 7
Collecorvino 7
Columbus 7
Macerata 7
Olomouc 7
Senigallia 7
Warsaw 7
Zhengzhou 7
Charlotte 6
Curitiba 6
Düsseldorf 6
Guarulhos 6
Hyderabad 6
Mexico City 6
Romola 6
Rouen 6
Saint-Saens 6
Totale 7.364
Salva come PNG Salva come JPEG
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 148
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 146
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 137
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 136
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 128
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 120
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 118
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 118
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 116
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 115
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 115
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 114
L’allergoide monomerico agisce anche sul GALT 114
Anti-Thyroid Effect of Resveratrol 109
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 107
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 107
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 107
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 106
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 105
Resveratrol has anti-thyroid effects both in vitro and in vivo 105
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 105
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 103
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 103
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 103
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 103
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 102
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 102
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 102
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 101
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 100
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 100
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 100
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 100
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 100
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 99
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 99
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 99
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 98
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 98
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 98
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 97
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 97
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 97
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 97
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 96
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 96
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 96
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 95
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 95
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 94
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 93
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 93
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 92
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 92
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 91
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 91
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 91
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 90
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 89
Neutrophils in anti-cancer immunological strategies: old players in new games 89
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 89
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 89
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 89
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 89
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 88
Antimetastatic activity of a preventive cancer vaccine. 88
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 87
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 87
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 87
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 86
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 85
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 85
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 85
Stem Cell Emergence After HBO In Volunteers 84
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 84
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 83
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 83
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 83
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 83
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 82
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 82
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 82
p130Cas is an essential transducer element in ErbB2 transformation. 82
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 82
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects. 82
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 81
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 81
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 81
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 80
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 80
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 80
Phospholipase Cgamma1 is required for metastasis development and progression 79
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 79
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 78
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 78
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. 77
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. 77
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 77
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 77
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 76
Totale 9.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021797 0 17 150 12 88 165 27 10 58 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.929 173 490 388 102 94 136 205 194 294 130 325 398
2025/2026597 491 106 0 0 0 0 0 0 0 0 0 0
Totale 12.740